241 related articles for article (PubMed ID: 28446295)
1. [Circulating Serum MicroRNA as Diagnostic Biomarkers for Multiple Myeloma].
Xu YN; Xiao CR; Huang YD; Lu QY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):471-475. PubMed ID: 28446295
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of circulatory microRNA-203 in serum as novel potential diagnostic marker for multiple myeloma.
Gupta N; Kumar R; Seth T; Garg B; Sati HC; Sharma A
J Cancer Res Clin Oncol; 2019 Jun; 145(6):1601-1611. PubMed ID: 30891618
[TBL] [Abstract][Full Text] [Related]
3. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer.
Huang Z; Huang D; Ni S; Peng Z; Sheng W; Du X
Int J Cancer; 2010 Jul; 127(1):118-26. PubMed ID: 19876917
[TBL] [Abstract][Full Text] [Related]
4. Circulating miRNAs as diagnostic biomarkers for multiple myeloma and monoclonal gammopathy of undetermined significance.
Li J; Zhang M; Wang C
J Clin Lab Anal; 2020 Jun; 34(6):e23233. PubMed ID: 32039495
[TBL] [Abstract][Full Text] [Related]
5. Identification of circulating microRNAs as diagnostic biomarkers for use in multiple myeloma.
Jones CI; Zabolotskaya MV; King AJ; Stewart HJ; Horne GA; Chevassut TJ; Newbury SF
Br J Cancer; 2012 Dec; 107(12):1987-96. PubMed ID: 23169280
[TBL] [Abstract][Full Text] [Related]
6. Circulating Serum MicroRNA-130a as a Novel Putative Marker of Extramedullary Myeloma.
Besse L; Sedlarikova L; Kryukov F; Nekvindova J; Radova L; Slaby O; Kuglik P; Almasi M; Penka M; Krejci M; Adam Z; Pour L; Sevcikova S; Hajek R
PLoS One; 2015; 10(9):e0137294. PubMed ID: 26389804
[TBL] [Abstract][Full Text] [Related]
7. Association of the peripheral blood levels of circulating microRNAs with both recurrent miscarriage and the outcomes of embryo transfer in an in vitro fertilization process.
Yang Q; Gu WW; Gu Y; Yan NN; Mao YY; Zhen XX; Wang JM; Yang J; Shi HJ; Zhang X; Wang J
J Transl Med; 2018 Jul; 16(1):186. PubMed ID: 29973278
[TBL] [Abstract][Full Text] [Related]
8. Circulating miR-17-3p, miR-29a, miR-92a and miR-135b in serum: Evidence against their usage as biomarkers in colorectal cancer.
Faltejskova P; Bocanek O; Sachlova M; Svoboda M; Kiss I; Vyzula R; Slaby O
Cancer Biomark; 2012; 12(4):199-204. PubMed ID: 23568010
[TBL] [Abstract][Full Text] [Related]
9. Technical factors involved in the measurement of circulating microRNA biomarkers for the detection of colorectal neoplasia.
Yamada A; Cox MA; Gaffney KA; Moreland A; Boland CR; Goel A
PLoS One; 2014; 9(11):e112481. PubMed ID: 25405754
[TBL] [Abstract][Full Text] [Related]
10. Circulating serum microRNAs as novel diagnostic and prognostic biomarkers for multiple myeloma and monoclonal gammopathy of undetermined significance.
Kubiczkova L; Kryukov F; Slaby O; Dementyeva E; Jarkovsky J; Nekvindova J; Radova L; Greslikova H; Kuglik P; Vetesnikova E; Pour L; Adam Z; Sevcikova S; Hajek R
Haematologica; 2014 Mar; 99(3):511-8. PubMed ID: 24241494
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the Diagnostic Potential of miR-29a-3p and miR-92a-3p as Circulatory Biomarkers in Acute Myeloid Leukemia.
Gado MM; Mousa NO; Badawy MA; El Taweel MA; Osman A
Asian Pac J Cancer Prev; 2019 Dec; 20(12):3625-3633. PubMed ID: 31870103
[TBL] [Abstract][Full Text] [Related]
12. Circulating miR-448 acts as a potential diagnostic biomarker for multiple myeloma.
Chen D; Chen T; Wang L; Zhang Z; Xing E
Hematology; 2022 Dec; 27(1):847-852. PubMed ID: 35938956
[TBL] [Abstract][Full Text] [Related]
13. A panel of circulating miRNAs as diagnostic biomarkers for screening multiple myeloma: a systematic review and meta-analysis.
Zhang L; Cao D; Tang L; Sun C; Hu Y
Int J Lab Hematol; 2016 Dec; 38(6):589-599. PubMed ID: 27870469
[TBL] [Abstract][Full Text] [Related]
14. The use of circulating microRNAs as diagnostic biomarkers in colorectal cancer.
Clancy C; Joyce MR; Kerin MJ
Cancer Biomark; 2015; 15(2):103-13. PubMed ID: 25547322
[TBL] [Abstract][Full Text] [Related]
15. Circulating microRNA signature for the diagnosis of very high-risk prostate cancer.
Alhasan AH; Scott AW; Wu JJ; Feng G; Meeks JJ; Thaxton CS; Mirkin CA
Proc Natl Acad Sci U S A; 2016 Sep; 113(38):10655-60. PubMed ID: 27601638
[TBL] [Abstract][Full Text] [Related]
16. Circulating miR-21, miR-29a, and miR-126 are associated with premature death risk due to cancer and cardiovascular disease: the JACC Study.
Yamada H; Suzuki K; Fujii R; Kawado M; Hashimoto S; Watanabe Y; Iso H; Fujino Y; Wakai K; Tamakoshi A
Sci Rep; 2021 Mar; 11(1):5298. PubMed ID: 33674633
[TBL] [Abstract][Full Text] [Related]
17. Circulating microRNA profiles in plasma: identification of miR-224 as a novel diagnostic biomarker in hepatocellular carcinoma independent of hepatic function.
Okajima W; Komatsu S; Ichikawa D; Miyamae M; Kawaguchi T; Hirajima S; Ohashi T; Imamura T; Kiuchi J; Arita T; Konishi H; Shiozaki A; Moriumura R; Ikoma H; Okamoto K; Taniguchi H; Itoh Y; Otsuji E
Oncotarget; 2016 Aug; 7(33):53820-53836. PubMed ID: 27462777
[TBL] [Abstract][Full Text] [Related]
18. The diagnostic efficacy of circulating miRNAs in monitoring the early development of colitis-induced colorectal cancer.
El-Daly SM; Morsy SM; Medhat D; El-Bana MA; Latif YA; Omara EA; Awadallah JR; Gamal-Eldeen AM
J Cell Biochem; 2019 Oct; 120(10):16668-16680. PubMed ID: 31095784
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic performance of microRNA-29a for colorectal cancer: a meta-analysis.
Zhi ML; Liu ZJ; Yi XY; Zhang LJ; Bao YX
Genet Mol Res; 2015 Dec; 14(4):18018-25. PubMed ID: 26782449
[TBL] [Abstract][Full Text] [Related]
20. The role of circulating miRNAs in multiple myeloma.
Zhang J; Xiao X; Liu J
Sci China Life Sci; 2015 Dec; 58(12):1262-9. PubMed ID: 26607481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]